These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9081963)

  • 21. [Benign thyroid disease: 20-year experience in surgical therapy].
    Zaraca F; Di Paola M; Gossetti F; Proposito D; Filippoussis P; Montemurro L; Mancini B; Gallina S; Talarico E; Talarico C; Lazzaro M; Mulieri G; Flati D; Flati G; Carboni M
    Chir Ital; 2000; 52(1):41-7. PubMed ID: 10832525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
    Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
    Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The management of thyrotoxicosis: a schematic approach].
    Papi G; Carapezzi C; Corsello SM
    Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postoperative complications in total thyroidectomy for Graves disease: comparison with multinodular benign goiter surgery].
    Biet A; Zaatar R; Strunski V; Page C
    Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):190-5. PubMed ID: 19596221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
    Mishra A; Mishra SK
    J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should the primary treatment of hyperthyroidism be surgical?
    Linos DA; Karakitsos D; Papademetriou J
    Eur J Surg; 1997 Sep; 163(9):651-7. PubMed ID: 9311471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the surgical treatment of thyrotoxicosis].
    Uchikov A; Nonchev B; Danev V; Murdzhev K; Vladeva S; Terzieva D
    Khirurgiia (Sofiia); 2006; (3):9-11. PubMed ID: 18788110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentre study of thyroid nodules in patients with Graves' disease.
    Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J
    Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid nodular disease: is it toxic or nontoxic, malignant or benign?
    Hurley DL; Gharib H
    Geriatrics; 1995 Jun; 50(6):24-6, 29-31. PubMed ID: 7768463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morbidity after subtotal and total thyroidectomy in patients with Graves' disease: the basis for decision-making regarding surgical indication and extent of resection].
    Dralle H; Sekulla C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():45-53. PubMed ID: 15255313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule.
    Boostrom S; Richards ML
    Otolaryngol Head Neck Surg; 2007 Feb; 136(2):278-81. PubMed ID: 17275554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of incidental parathyroidectomy after thyroidectomy for benign thyroid disorders.
    Erbil Y; Barbaros U; Ozbey N; Aral F; Ozarmağan S
    Int J Surg; 2009 Feb; 7(1):58-61. PubMed ID: 19027373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease.
    Ku CF; Lo CY; Chan WF; Kung AW; Lam KS
    ANZ J Surg; 2005 Jul; 75(7):528-31. PubMed ID: 15972039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients.
    Smith JJ; Chen X; Schneider DF; Broome JT; Sippel RS; Chen H; Solórzano CC
    J Am Coll Surg; 2013 Apr; 216(4):571-7; discussion 577-9. PubMed ID: 23403140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hyperthyroidisms in Brazzaville Teaching Hospital, Congo].
    Monabeka HG; Bouenizabila E; Ondzotto G
    Bull Soc Pathol Exot; 2005 Jun; 98(2):91-3. PubMed ID: 16050372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graves' disease occurring after surgery of a multinodular goiter: a case report.
    Heinzel A; Müller HW; Poeppel TD; Engers R; Hautzel H
    Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):95-7. PubMed ID: 18563680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.